BioStem Technologies, Inc. (BSEM) stock
BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$0.64−0.07 (-10.23%)
Close on Nov 20, 2026Market cap $11.34MP/E –Yield –
BioStem Technologies enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BioStem Technologies's enterprise value was $19.26M on Nov 11, 2026.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $19.26M | – |
See a number that looks wrong?